Mouse models of nonalcoholic steatohepatitis in preclinical drug development - ScienceDirect
A researcher's guide to preclinical mouse NASH models | Nature Metabolism
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis | Scientific Reports
Biomedicines | Free Full-Text | Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
Non-alcoholic Steatohepatitis (NASH) Models l GemPharmatech
GAN model - Biocytogen
Nonalcoholic Steatohepatitis NASH Models | Charles River
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better - Cellular and Molecular Gastroenterology and Hepatology
Pathophysiological features of NASH–HCC model mice. (A) Representative... | Download Scientific Diagram
Investigating fibrosis and inflammation in an ex vivo NASH murine model | American Journal of Physiology-Gastrointestinal and Liver Physiology
1 NASH (MASH) Model for Clinical Translatability | Gubra
Frontiers | Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
IJMS | Free Full-Text | Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice
![One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2021/05/c1008e24bbb678110a0cb988df414a97/preprints-42692-graphical.v2%20111.png "One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org")
One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org
JCI Insight - Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
JExpMed on X: ".@giobenegiamo et al. @Auwerx_Lab investigate how genetics affects non-alcoholic steatohepatitis (NASH) in mice. Only the PWK/PhJ strain develops severe hepatic #inflammation, #fibrosis and #mitochondria dysfunction and is a novel #
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
NASH mouse model|BioMice｜Biocytogen
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis | Scientific Reports
Protocol for the control and NASH experimental groups. Mice were... | Download Scientific Diagram
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis | American Journal of Physiology-Gastrointestinal and Liver Physiology
Successful establishment of the mouse NASH model. (A) Representative... | Download Scientific Diagram
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer - ScienceDirect
Mouse models of nonalcoholic steatohepatitis and their application to new drug development | Archives of Pharmacal Research
